MAXHEALTH - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 2.9
| Stock Code | MAXHEALTH | Market Cap | 95,008 Cr. | Current Price | 977 ₹ | High / Low | 1,314 ₹ |
| Stock P/E | 137 | Book Value | 87.4 ₹ | Dividend Yield | 0.15 % | ROCE | 12.5 % |
| ROE | 9.45 % | Face Value | 10.0 ₹ | DMA 50 | 1,048 ₹ | DMA 200 | 1,105 ₹ |
| Chg in FII Hold | -1.25 % | Chg in DII Hold | 1.17 % | PAT Qtr | 160 Cr. | PAT Prev Qtr | 166 Cr. |
| RSI | 36.7 | MACD | -27.8 | Volume | 42,47,305 | Avg Vol 1Wk | 46,67,410 |
| Low price | 940 ₹ | High price | 1,314 ₹ | PEG Ratio | 4.34 | Debt to equity | 0.08 |
| 52w Index | 9.80 % | Qtr Profit Var | -30.6 % | EPS | 6.60 ₹ | Industry PE | 45.2 |
📊 Chart Patterns & Trend: Max Healthcare is trading at 977 ₹, below both its 50 DMA (1,048 ₹) and 200 DMA (1,105 ₹). This indicates a bearish consolidation with downward bias. The stock is near its 52-week low (940 ₹), reflecting weak sentiment and selling pressure.
📈 RSI: At 36.7, RSI is approaching oversold territory, suggesting limited downside but weak momentum.
📉 MACD: Negative at -27.8, confirming bearish momentum and lack of bullish crossover signals.
📊 Bollinger Bands: Price is near the lower band, indicating oversold conditions and possible mean reversion.
📊 Volume Trends: Current volume (42,47,305) is slightly lower than average weekly volume (46,67,410), showing reduced participation and lack of conviction in recent moves.
🎯 Entry Zone: 950–975 ₹ (near support and oversold RSI).
🎯 Exit Zone: 1,040–1,080 ₹ (near 50 DMA resistance).
Positive
- Market cap of 95,008 Cr. reflects strong presence in healthcare sector.
- DII holdings increased by 1.17%, showing domestic institutional confidence.
- Debt-to-equity ratio at 0.08 shows low leverage.
- EPS at 6.60 ₹ supports earnings visibility.
Limitation
- Stock trading below both 50 DMA and 200 DMA, showing weak momentum.
- High P/E of 137 compared to industry PE of 45.2, making valuation expensive.
- Dividend yield is negligible at 0.15%.
- PEG ratio of 4.34 indicates poor earnings growth relative to valuation.
- ROCE (12.5%) and ROE (9.45%) are modest, limiting long-term compounding potential.
Company Negative News
- Quarterly PAT declined to 160 Cr. from 166 Cr.
- Quarterly profit variance of -30.6% highlights declining profitability.
- FII holdings decreased (-1.25%), showing reduced foreign investor confidence.
Company Positive News
- DII stake increase reflects domestic investor confidence.
- Debt-free balance sheet provides financial stability.
- EPS growth supports long-term earnings visibility.
Industry
- Healthcare sector trading at industry PE of 45.2, highlighting Max Healthcare’s premium valuation.
- Sector outlook remains positive with rising demand for healthcare services and infrastructure expansion.
Conclusion
⚖️ Max Healthcare is in a bearish consolidation phase with weak RSI and negative MACD. Entry near 950–975 ₹ offers margin of safety, while exits around 1,040–1,080 ₹ provide profit-taking opportunities. Long-term investors should be cautious due to high valuations and modest ROE/ROCE, while short-term traders may exploit oversold conditions for swing trades.
Selva, this is workflow-ready. Would you like me to also prepare a standardized HTML template with placeholders for peer benchmarking overlays and sector scans, so you can plug multiple stocks seamlessly into your automation system?